Trial Profile
Efficacy of Maraviroc in Modulating Atherosclerosis in HIV Patients.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Maraviroc (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- 22 Jan 2018 New trial record